You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Osteosarcoma Recurrent

Showing 1 - 25 of 8,005
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent Trial in United States (Regorafenib 40 MG, Regorafenib 20MG,

Recruiting
  • Osteosarcoma
  • +3 more
  • Regorafenib 40 MG
  • +2 more
  • Los Angeles, California
  • +7 more
Jan 19, 2023

Pulmonary Osteosarcoma Trial (RNA-LP vaccine)

Not yet recruiting
  • Pulmonary Osteosarcoma
  • RNA-LP vaccine
  • (no location specified)
Jan 25, 2023

High Dose Isofosfamide Through Elastomer

Active, not recruiting
  • Osteosarcoma Recurrent
  • Observational study
  • Bologna, Italy
  • +4 more
Aug 11, 2022

Osteosarcoma Trial in United States (Avelumab, Questionnaires)

Active, not recruiting
Has Results
  • Osteosarcoma
  • Los Angeles, California
  • +3 more
Aug 22, 2022

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Osteosarcoma Trial (Vactosertib)

Not yet recruiting
  • Osteosarcoma
  • (no location specified)
Oct 18, 2022

Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory

Active, not recruiting
Has Results
  • Metastatic Ewing Sarcoma
  • +9 more
  • Cabozantinib S-malate
  • Laboratory Biomarker Analysis
  • Bordeaux, France
  • +10 more
Nov 26, 2022

Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)

Not yet recruiting
  • Osteogenic Sarcoma Recurrent
  • Hackensack, New Jersey
  • +1 more
Feb 3, 2023

Osteosarcoma Metastatic, Ewing's Sarcoma Metastatic Trial in Miami (Chemotherapy (gemcitabine & docetaxel) plus BIO-11006)

Active, not recruiting
  • Osteosarcoma Metastatic
  • Ewing's Sarcoma Metastatic
  • Chemotherapy (gemcitabine & docetaxel) plus BIO-11006
  • Miami, Florida
    Nicklaus Children's Hospital
Nov 8, 2022

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma

    Completed
    • Osteosarcoma Recurrent
    • Osteosarcoma Metastatic
    • observation
    • Milan, Milano, Italy
    • +7 more
    Nov 24, 2021

    DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma

    Completed
    • Localized Osteosarcoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Mar 11, 2022

    Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

    Recruiting
    • Recurrent Neuroblastoma
    • +3 more
    • Palo Alto, California
    • +3 more
    Jan 25, 2023

    Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

    Not yet recruiting
    • Liver Transplant; Complications
    • +3 more
    • multi-kinase inhibitors in combination with bevacizumab
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Sep 11, 2023

    High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

    Recruiting
    • High Risk Neuroblastoma
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +10 more
    Jan 19, 2023

    Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)

    Suspended
    • Osteosarcoma
    • Recurrent Osteosarcoma
    • Trastuzumab Deruxtecan
    • Birmingham, Alabama
    • +27 more
    Oct 21, 2022

    Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

    Recruiting
    • Recurrent Solid Tumor
    • +21 more
    • Palo Alto, California
    • +8 more
    Jun 7, 2022

    Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

    Recruiting
    • Colorectal Carcinoma
    • +21 more
    • Dual X-ray Absorptiometry
    • +2 more
    • Birmingham, Alabama
    • +18 more
    Jan 30, 2023

    Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • +22 more
    • Ipilimumab
    • +3 more
    • Birmingham, Alabama
    • +24 more
    Jan 19, 2023

    Solid Tumor, Lymphoma, Osteosarcoma Trial in Orange (Surufatinib in combination with Gemcitabine)

    Recruiting
    • Solid Tumor
    • +5 more
    • Surufatinib in combination with Gemcitabine
    • Orange, California
      Childrens Hospital Orange County
    Feb 8, 2022

    Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma Trial in Houston (Durvalumab,

    Recruiting
    • Metastatic Angiosarcoma
    • +7 more
    • Durvalumab
    • Oleclumab
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2021

    Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate

    Recruiting
    • Recurrent or Refractory Solid Tumors
    • +4 more
    • MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
    • Cincinnati, Ohio
    • +5 more
    Mar 17, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

    Recruiting
    • Bone Sarcoma
    • +15 more
    • Aldesleukin
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

    Recruiting
    • Neuroblastoma
    • +5 more
    • GD2-CART01
    • Roma, Italy
      Ospedale Pediatrico Bambino Gesù
    Mar 9, 2022